Skip to main content

Table 6 Comparison between the percentage of major adverse effect between enhancement and non-enhancement groups in study

From: Delayed myocardial enhancement in children with different types of cardiomyopathy: a diagnostic and prognostic tool

  Non-enhancement Enhancement p value
Major adverse effect
No 14 (87.5%) 3 (20%) *p ≤0.001
Yes 2 (12.5%) 12 (80%)